A. Bretteville

发表

Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology

H. Soininen, L. Buée, J. Lambert, 2016, Molecular Psychiatry.

Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

A. Delacourte, F. Pasquier, L. Buée, 2008, Expert review of proteomics.

p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death

A. Delacourte, L. Buée, K. Schindowski, 2005, Journal of Cell Science.

Proximity Ligation Assay: A Tool to Study Endogenous Interactions Between Tau and Its Neuronal Partners.

J. Chapuis, F. Demiautte, A. Bretteville, 2017, Methods in molecular biology.

Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation

J. Charron, T. Maurin, L. Virág, 2013, Scientific Reports.

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia

D. Dickson, K. Duff, L. Virág, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro

L. Virág, A. Bretteville, E. Planel, 2015, Neurobiology of Aging.

Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice

S. Hébert, P. Mathews, A. Amrani, 2013, Diabetes.

Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes

J. Reumers, R. de Hoogt, A. Buist, 2018, Stem cell reports.

Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker

L. Buée, I. Landrieu, G. Lippens, 2013, Neurobiology of Aging.

Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders.

J. Bartolomé-Nebreda, F. Delgado, Carlos M Martínez-Viturro, 2020, Journal of medicinal chemistry.

Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation

S. Hébert, A. Bretteville, E. Planel, 2012, PloS one.

P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

L. Buée, J. Brion, K. Leroy, 2006, The American journal of pathology.

Insulin dysfunction and Tau pathology

A. Bretteville, E. Planel, Noura B. El Khoury, 2013, Front. Cell. Neurosci..

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors

S. Hébert, G. Lévesque, A. Bretteville, 2012, Scientific Reports.

Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models

Nicolas Moindrot, G. Nabel, Yaming Wang, 2018, Glia.

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment

Ottavio Arancio, O. Arancio, Lili Wang, 2008, Neurobiology of Disease.

Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions

S. Hébert, F. Calon, A. Bretteville, 2014, PloS one.

Anesthesia and tau pathology

A. Bretteville, E. Planel, R. Whittington, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation

L. Buée, K. Ando, K. Schindowski, 2007, Genes, brain, and behavior.

Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability In Vivo

P. Davies, A. Takashima, R. Nixon, 2008, The Journal of Neuroscience.

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.

L. Buée, E. Gilissen, J. Brion, 2007, The American journal of pathology.

Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

A. Bretteville, E. Planel, C. Julien, 2012, Methods in molecular biology.

Tau aggregates: toxic, inert, or protective species?

A. Bretteville, E. Planel, 2008, Journal of Alzheimer's disease : JAD.

Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format

A. Buist, A. Ebneth, A. Verheyen, 2016, Journal of biomolecular screening.

Two-Dimensional Electrophoresis of Tau Mutants Reveals Specific Phosphorylation Pattern Likely Linked to Early Tau Conformational Changes

L. Buée, A. Ghestem, N. Sergeant, 2009, PloS one.

Pin1 allows for differential Tau dephosphorylation in neuronal cells

A. Delacourte, L. Buée, G. Lippens, 2006, Molecular and Cellular Neuroscience.

Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain

J. Lambert, P. Amouyel, I. Landrieu, 2015, Acta neuropathologica communications.

IP-LC-MSMS Enables Identification of Three Tau O-GlcNAcylation Sites as O-GlcNAcase Inhibition Pharmacodynamic Readout in Transgenic Mice Overexpressing Human Tau.

J. Bartolomé-Nebreda, L. Dillen, A. Ebneth, 2023, Journal of proteome research.

Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes

J. Reumers, R. de Hoogt, A. Buist, 2019, Stem cell reports.

P1-062 Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

L. Buée, J. Brion, K. Leroy, 2006, Alzheimer's & Dementia.